Showing 9,241 - 9,260 results of 32,532 for search '(( 50 ((ng decrease) OR (((a decrease) OR (mean decrease)))) ) OR ( e point decrease ))', query time: 1.18s Refine Results
  1. 9241

    A Reduce and Replace Strategy for Suppressing Vector-Borne Diseases: Insights from a Stochastic, Spatial Model by Kenichi W. Okamoto (500514)

    Published 2013
    “…We find this “reduce and replace” strategy can decrease the frequency of competent vectors below 50% two years after releases end. …”
  2. 9242
  3. 9243
  4. 9244

    Passive sensing data. by Thierry Jean (20691795)

    Published 2025
    “…The CrossCheck dataset includes 6,364 mental state surveys using 4-point ordinal rating scales and 23,551 days of smartphone sensor data contributed by patients with schizophrenia. …”
  5. 9245

    Surveys. by Thierry Jean (20691795)

    Published 2025
    “…The CrossCheck dataset includes 6,364 mental state surveys using 4-point ordinal rating scales and 23,551 days of smartphone sensor data contributed by patients with schizophrenia. …”
  6. 9246
  7. 9247

    Probing the Sensitivity of the Orbitrap Lumos Mass Spectrometer Using a Standard Reference Protein in a Complex Background by Michaella J. Levy (1564081)

    Published 2018
    “…In contrast, when the peptides and fragments were both detected in the Orbitrap on either the Lumos or Q-Exactive Plus (FTFT mode), the lowest concentration of NIST monoclonal antibody detected was 50 pg. The Lumos can detect a single protein at a level 2500 times lower than the whole cell background and the combination of detecting ions in the Orbitrap and ion trap can improve the identification of low abundance proteins. …”
  8. 9248

    A Novel Splice-Site Mutation in Angiotensin I-Converting Enzyme (ACE) Gene, c.3691+1G>A (IVS25+1G>A), Causes a Dramatic Increase in Circulating ACE through Deletion of the Transmem... by Alexandre Persu (396983)

    Published 2013
    “…The levels of renin-angiotensin-aldosterone system components in the mutated cases and wild-type controls were similar, both at baseline and after 50 mg captopril. Compared with non-affected members, quantification of ACE surface expression and shedding using flow cytometry assay of dendritic cells derived from peripheral blood monocytes of affected members, demonstrated a 50% decrease and 3-fold increase, respectively. …”
  9. 9249

    A- and D‑Ring Structural Modifications of an Androsterone Derivative Inhibiting 17β-Hydroxysteroid Dehydrogenase Type 3: Chemical Synthesis and Structure–Activity Relationships... by Francisco Cortés-Benítez (4523380)

    Published 2019
    “…Decreasing the intratumoral androgen biosynthesis by using an inhibitor of 17β-hydroxysteroid dehydrogenase type 3 (17β-HSD3) is a strategy to treat prostate cancer. …”
  10. 9250
  11. 9251

    Demographic characteristics of the survey sample. by Stephanie Niño de Rivera (19501049)

    Published 2024
    “…Overall, 50% of the sample identified as women, 13% as Black or African American, and 7% as Hispanic or Latino, with a mean age of 46 years. …”
  12. 9252
  13. 9253
  14. 9254
  15. 9255
  16. 9256
  17. 9257

    Presentation_1_Low-Dose Mycophenolate Mofetil for Treatment of Neuromyelitis Optica Spectrum Disorders: A Prospective Multicenter Study in South China.PPTX by Qiao Huang (4386955)

    Published 2018
    “…The serum AQP4-IgG titer decreased in 50 cases (63%). The median Simple McGill pain score (SF-MPQ) was reduced in 65 patients (88%) with myelitis from 17 (range 0–35) to 11 (range 0–34) after treatment (P < 0.0001). …”
  18. 9258
  19. 9259

    A vaginal drug delivery model by Mohd. Aamir Mirza (2561590)

    Published 2016
    “…Stearic acid and Compritol 888 (1:1, w/w ratio) as lipid, a mixture of 3% Poloxomer 188 and 0.5% sodium taurocholate as surfactant and organic to aqueous ratio of 10:50 was taken. …”
  20. 9260

    Mutant S gene segment plasmid design. by Debarpan Dhar (724473)

    Published 2024
    “…The S1 UTRs, while not sufficient, were necessary for efficient packaging, as mutations of the 5′ or 3′ UTRs led to a complete loss of virus recovery. Using a second novel assay, we determined that 50 5′ nts and 50 3′ nts of S1 are sufficient to package a non-viral gene segment into MRV. …”